New biosensors aim to diagnose infections in minutes
NCT ID NCT06548841
First seen Jun 25, 2026 · Last updated Jun 27, 2026 · Updated 2 times
Summary
This study tested two new types of biosensor platforms to detect viruses, bacteria, and parasites in blood and respiratory samples. The goal was to see if these devices could be accurate, fast, and cheap alternatives to standard lab tests. Researchers enrolled 149 adults with or without SARS-CoV-2, Pseudomonas aeruginosa, or Leishmania infantum infections.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
Active substance
Nanobiotechnology platforms (biosensors using molecular probes or bacteriophages)
What this could lead to
If successful, these biosensors could provide fast, low-cost diagnosis for infections like COVID-19, Pseudomonas, and Leishmania, especially in low-resource settings.
What could go wrong
This is a completed early-stage feasibility study with 149 participants. The results may not confirm real-world accuracy, and the technology may not be scalable or reliable across different settings.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for SARS-COV-2 INFECTION are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Department of Medical and Surgical Sciences, University of Bologna
Bologna, Bologna, 40138, Italy